Q2 2025 Earnings Conference Call August 4, 2025 4:30 PM ETCompany ParticipantsAJ Schwabe - Corporate ParticipantBruce C.

Hello, everyone. This is Thomas Kudsk Larsen from the Sanofi IR team. Welcome to the Q2 2025 conference call for investors ...

Actuate Therapeutics' elraglusib shows promise in metastatic pancreatic cancer. Upcoming FDA meeting may accelerate approval.

The horror-comedy, elegantly set in rural Karnataka, also features the versatile Raj B. Shetty in an intriguing role. The ...

Productive FDA Meeting Highlights Path Toward Overdose Protection Labeling and 505(b)(2) Regulatory Strategy ~~ FDA and Ensysce Aligned on Collaborative Approach to Ensure Product's Full Safety ...

As B2B marketers work to modernize GTM strategies and scale impact, 2X's Lisa Cole has written an alternative to the ...

Golnaz Arastoopour Irgens, assistant professor of human-centered technologies at Vanderbilt University and a former middle ...

Entergy Corporation (NYSE: ETR) reported second quarter 2025 earnings per share of $1.05 on an as-reported and an adjusted ...

Operator: Good morning, and welcome to the Dorian LPG First Quarter 2026 Earnings Conference Call. [Operator Instructions] As ...

Magnolia reported second quarter 2025 net income attributable to Class A Common Stock of $78.1 million, or $0.41 per diluted ...

Operator: Hello, everyone, and welcome to COMPASS Pathways Second Quarter 2025 Earnings Conference Call. Please note that ...

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the European Medicines Agency (EMA) has ...